Home › Funds › AYAL Capital Advisors Ltd › SHC
AYAL Capital Advisors Ltd position in SHC
SOTERA HEALTH CO · Health Care
AYAL Capital Advisors Ltd reported holding 362,000 shares of SHC (SOTERA HEALTH CO) in its Q2 2026 13F filing — a position valued at US$6.4M, representing 1.78% of its reported portfolio and ranking #16 among its reported holdings. AYAL Capital Advisors Ltd has disclosed SHC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How AYAL Capital Advisors Ltd's SHC position evolved
AYAL Capital Advisors Ltd first disclosed a stake in SHC in Q1 2026 at 180,000 shares (US$2.6M). The position peaked in Q2 2026 at 362,000 shares, worth US$6.4M. Across 2 filings, AYAL Capital Advisors Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 362,000 shares valued at US$6.4M — an increase of 182,000 shares quarter over quarter.. Notable position changes include a 101% increase in Q2 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 180.00K | $2.58M | New |
| Q2 2026 | 362.00K | $6.43M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SHC and 13F data
SHC (SOTERA HEALTH CO) is a Health Care company. 48 other funds we track also report a position in SHC — the largest reported positions include Sessa Capital IM, L.P. (US$480.1M), Darsana Capital Partners LP (US$479.2M), Sculptor Capital LP (US$426.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SHC
- Sessa Capital IM, L.P. 27.05M sh · $480.14M · Q2 2026
- Darsana Capital Partners LP 27.00M sh · $479.25M · Q2 2026
- Sculptor Capital LP 24.00M sh · $426.00M · Q2 2026
- Sachem Head Capital Management LP 15.56M sh · $276.19M · Q2 2026
- Two Seas Capital LP 6.11M sh · $112.99M · Q3 2026
- Voss Capital, LP 5.83M sh · $103.39M · Q2 2026
- Irenic Capital Management LP 5.14M sh · $91.27M · Q2 2026
- DME Capital Management, LP 4.14M sh · $73.41M · Q2 2026
- LAKEWOOD CAPITAL MANAGEMENT, LP 3.98M sh · $70.64M · Q2 2026
- ION Fund Management Ltd 3.34M sh · $59.35M · Q2 2026
- DENDUR CAPITAL LP 2.77M sh · $49.17M · Q2 2026
- Ancora Advisors LLC 2.68M sh · $47.63M · Q2 2026
More on AYAL Capital Advisors Ltd
FAQ
How long has AYAL Capital Advisors Ltd held SHC?
AYAL Capital Advisors Ltd has disclosed SHC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is AYAL Capital Advisors Ltd's current position in SHC?
As of Q2 2026, AYAL Capital Advisors Ltd holds 362.00K shares of SHC (SOTERA HEALTH CO), valued at $6.43M, representing 1.78% of its reported portfolio and ranking #16.
Has AYAL Capital Advisors Ltd been buying or selling SHC?
In the latest 13F filing (Q2 2026), AYAL Capital Advisors Ltd increased its position in SHC. The position peaked in Q2 2026 at 362.00K shares.
Which other funds hold SHC?
Other major institutional holders of SHC include Sessa Capital IM, L.P., Darsana Capital Partners LP, Sculptor Capital LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.